Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cyclerion Therapeutics Inc
(NQ:
CYCN
)
2.510
-0.380 (-13.15%)
Streaming Delayed Price
Updated: 3:21 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cyclerion Therapeutics Inc
< Previous
1
2
3
4
5
Next >
Regina Graul, Ph.D., Promoted to Chief Executive Officer
August 07, 2024
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 21, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 21, 2024
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 22, 2024
Via
Benzinga
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024
May 08, 2024
Cyclerion Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023
April 05, 2024
Cyclerion Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 11, 2024
Via
Benzinga
Cyclerion Appoints Regina Graul, Ph.D., as President
December 04, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
December 01, 2023
Via
Benzinga
Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 01, 2023
Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.
Via
Benzinga
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
November 30, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 10, 2023
Via
Benzinga
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
July 31, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement
June 01, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 16, 2023
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.
Via
Benzinga
Cyclerion Announces Reverse Stock Split
May 15, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors
May 12, 2023
Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (formerly CY6463) and CY3018, to a new private company ("NewCo") formed by certain current Cyclerion...
Via
Benzinga
Cyclerion Announces Corporate Updates and Q1 2023 Financial Results
May 11, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
May 11, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 26, 2023
Via
Benzinga
Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement
April 03, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.